CommercialBilling CodesHigh impact
Provider-Administered Drugs Coding Policy
Blue Cross & Blue Shield of Mississippi·MS · Oncology, Rheumatology, Endocrinology +4 more·Coding
Effective date
Jan 1, 2023
We identified it
Jun 20, 2026
Summary
BCBS of Mississippi updated their provider-administered drugs coding policy, requiring specific CPT codes for drug administration (96372, 96401, 96402) with mandatory 11-digit NDC reporting in loop 2410, and prohibiting chemotherapy administration codes for certain subcutaneous/intramuscular drugs that must use CPT 96372 instead.
Action Required
Immediately: Billing team must update system to require 11-digit NDC codes in loop 2410 for all subcutaneous/intramuscular drug administrations using CPT 96372, 96401, or 96402. Stop using chemotherapy administration codes (96401-96549) for the listed drugs including Fasenra, Ilaris, Cimzia, Prolia, Neupogen, and others - use CPT 96372 instead. Add modifier -JW for discarded drug portions. Update encounter forms to capture NDC and quantity information. Claims may be denied without proper NDC reporting and correct administration codes.